{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Among cardiologists, it has become a running joke: maybe the powerful drugs known as statins should be added to the water supply. Not only do statins greatly reduce cholesterol and lower mortality in people at risk for heart attacks, but some studies also suggest that they might help to prevent or treat a wide range of ailments, including Alzheimer's disease, multiple sclerosis, bone fractures, some types of cancer, macular degeneration and glaucoma. An estimated 11 million Americans take statins. With new government recommendations issued last week, millions more are likely to begin taking the drugs, and many who already take them are likely to have their dosages increased.", "headline": {"main": "Seeking A Fuller Picture Of Statins"}, "abstract": "Eleven million Americans take statins to lower cholesterol; recent studies suggest that statins can also be useful in treatment of Alzheimer's disease, multiple sclerosis, some cancers and macular degeneration; effects of longterm statin use are unknown and some experts are concerned that more testing on statins should be completed before doctors begin even more sweeping use of drug for patients; Dr Beatrice A Golomb, University of California, San Diego, associate professor and lead investigator of large federally financed study on effects of statins on noncardiac processes, holds that drug companies are too involved in statin research and review process; has documented about 500 cases of people who experienced adverse side effects, like disorientation and muscle weakness, while on statins (L)", "print_page": "5", "word_count": 1666, "_id": "4fd2a2d78eb7c8105d8888d9", "snippet": "Among cardiologists, it has become a running joke: maybe the powerful drugs known as statins should be added to the water supply. Not only do statins greatly reduce cholesterol and lower mortality in people at risk for heart attacks, but some studies...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/07/20/health/seeking-a-fuller-picture-of-statins.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GOLOMB, BEATRICE A"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "UNIVERSITY OF CALIFORNIA"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "ALZHEIMER'S DISEASE"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MUSCLES"}, {"name": "subject", "value": "STATINS (CHOLESTEROL-LOWERING DRUGS)"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "MACULAR DEGENERATION"}, {"name": "subject", "value": "MULTIPLE SCLEROSIS"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "CHOLESTEROL"}, {"name": "subject", "value": "EYES AND EYESIGHT"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "David", "lastname": "TULLER"}], "original": "By DAVID TULLER"}, "document_type": "article", "pub_date": "2004-07-20T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Bayer, the German chemical and drug giant that makes aspirin and Alka-Seltzer, said Monday that it would buy the over-the-counter drug business of the Swiss pharmaceuticals company Roche in a transaction worth about $2.95 billion that would create a world leader in nonprescription medicines. If the 2.38 billion euro deal is approved by antitrust officials in Europe and the United States, the enlarged Bayer consumer health care unit, which would continue to be based in Morristown, N.J., would be led by Gary S. Balkema, the president of Bayer Healthcare. The combined operations would have 6,700 employees in 120 countries.", "headline": {"main": "Bayer in Deal For Roche's Consumer Unit"}, "abstract": "German chemical and drug giant Bayer will buy Swiss pharmaceutical company Roche's over-the-counter drug business in deal worth about 2.38 billion euros ($2.95 billion); deal would enlarge Bayer's New Jersey-based consumer health care unit; graph of largest nonprescription drug makers; photo (M)", "print_page": "1", "word_count": 742, "_id": "4fd2a2d78eb7c8105d8888db", "snippet": "Bayer, the German chemical and drug giant that makes aspirin and Alka-Seltzer, said Monday that it would buy the over-the-counter drug business of the Swiss pharmaceuticals company Roche in a transaction worth about $2.95 billion that would create a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/07/20/business/bayer-in-deal-for-roche-s-consumer-unit.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "ROCHE AG"}, {"name": "organizations", "value": "BAYER AG"}, {"name": "subject", "value": "MERGERS, ACQUISITIONS AND DIVESTITURES"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Fiona", "lastname": "FLECK"}], "original": "By FIONA FLECK"}, "document_type": "article", "pub_date": "2004-07-20T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Sports Desk", "lead_paragraph": "WHEN Lance Armstrong arrives at the head of the pack next Sunday -- as he almost surely will -- he will deserve all the cheers as a strong and charismatic six-time champion of the Tour de France. But trailing right behind Armstrong, like a malevolent shadow, is the ugly culture of cycling -- eight riders who died in the past 15 months, at least 16 riders who have been yanked out of this Tour because of drugs.", "headline": {"main": "Sports of The Times; Armstrong's Toughest Rival May Be the Sport of Cycling"}, "abstract": "George Vecsey Sports of The Times column contends that cycling is among worst offenders for notorious drug use, and some insiders estimate as many as 90 percent of pro cyclists use banned substances; Lance Armstrong may win unprecented sixth Tour de France, but that will not likely allay suspicions that he too practices doping; photo (M)", "print_page": "1", "word_count": 1125, "_id": "4fd258168eb7c8105d80347c", "snippet": "WHEN Lance Armstrong arrives at the head of the pack next Sunday -- as he almost surely will -- he will deserve all the cheers as a strong and charismatic six-time champion of the Tour de France.     But trailing right behind Armstrong, like a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/07/19/sports/sports-of-the-times-armstrong-s-toughest-rival-may-be-the-sport-of-cycling.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "ARMSTRONG, LANCE"}, {"name": "subject", "value": "BICYCLES AND BICYCLING"}, {"name": "subject", "value": "SPORTS OF THE TIMES (TIMES COLUMN)"}, {"name": "subject", "value": "TOUR DE FRANCE (BICYCLE RACE)"}, {"name": "subject", "value": "DRUG ABUSE AND TRAFFIC"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "George", "lastname": "VECSEY"}], "original": "By GEORGE VECSEY"}, "document_type": "article", "pub_date": "2004-07-19T00:00:00Z", "section_name": "Sports"}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "When the Bush administration pushed its Medicare drug bill through a reluctant Congress, even supporters knew there were flaws that would have to be corrected. The fact that no serious fixes have been made, or even proposed by the White House, suggests that the whole impetus for the idea had more to do with presidential politics than with health care policy. Now, as the defects loom wider than ever, even the program's political appeal may be eroding. Government estimates published in The Times last week indicate that one of the biggest problems with the program -- the way it could encourage companies to drop drug benefits for their retirees in favor of the inferior federal program -- may be worse than originally thought. According to the new figures, companies may drop or reduce prescription drug coverage for 3.8 million retirees when the new drug benefit takes effect in 2006. That could rise to 4.1 million by 2010, a blow for more than one-third of retirees who are insured by their former employers.", "headline": {"main": "Prescription for Trouble"}, "abstract": "Editorial says Bush administration's failure to propose fixes to admittedly flawed Medicare drug bill suggests that its impetus for idea had more to do with presidential politics than health care policy; says if, as projected, new law guts existing benefits of millions of retirees, it could trigger political backlash that might threaten much-needed reform", "print_page": "16", "word_count": 435, "_id": "4fd27fbc8eb7c8105d84a271", "snippet": "When the Bush administration pushed its Medicare drug bill through a reluctant Congress, even supporters knew there were flaws that would have to be corrected. The fact that no serious fixes have been made, or even proposed by the White House,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/07/19/opinion/prescription-for-trouble.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE W"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "EDITORIALS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ELECTION ISSUES"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "PRESIDENTIAL ELECTION OF 2004"}], "byline": null, "document_type": "article", "pub_date": "2004-07-19T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "Review", "blog": [], "news_desk": "Book Review Desk", "lead_paragraph": "REASON Why Liberals Will Win the Battle for America. By Robert B. Reich. 257 pp. Alfred A. Knopf. $24. STAND UP FIGHT BACK Republican Toughs, Democratic Wimps, and the Politics of Revenge. By E. J. Dionne Jr. 243 pp. Simon & Schuster. $24.", "headline": {"main": "Are You Listening, Senator Kerry?"}, "abstract": "Will Saletan reviews following books: Reason: Why Liberals Will Win the Battle for America by Robert B Reich; and Stand Up Fight Back: Republican Toughs, Democratic Wimps, and the Politics of Revenge by E J Dionne Jr; drawing (M)", "print_page": "9", "word_count": 1420, "_id": "4fd253a08eb7c8105d7fa758", "snippet": "REASON   Why Liberals Will Win   the Battle for America.   By Robert B. Reich.   257 pp. Alfred A. Knopf. $24.     STAND UP FIGHT BACK   Republican Toughs, Democratic Wimps, and the Politics of Revenge.   By E. J. Dionne Jr.   243 pp. Simon &...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/07/18/books/are-you-listening-senator-kerry.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "REASON: WHY LIBERALS WILL WIN THE BATTLE FOR AMERICA (BOOK)"}, {"name": "creative_works", "value": "STAND UP FIGHT BACK (BOOK)"}, {"name": "persons", "value": "REICH, ROBERT B"}, {"name": "persons", "value": "DIONNE, E J JR"}, {"name": "subject", "value": "REVIEWS"}, {"name": "subject", "value": "BOOKS AND LITERATURE"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Will", "lastname": "Saletan"}], "original": "By Will Saletan"}, "document_type": "article", "pub_date": "2004-07-18T00:00:00Z", "section_name": "Arts; Books"}, {"type_of_material": "News", "blog": [], "news_desk": "Magazine Desk", "lead_paragraph": "When Vivienne Sales finally broke her silence, she did so loudly, losing her temper in the hushed library where she worked. It was August 2003, and she had been hanging on to her job as a reference librarian by the most fragile of threads. For more than a year her supervisors at the Embry-Riddle Aeronautical University in Prescott, Ariz., had been warning her that she was sometimes sloppy and inaccurate. She was late for work too often, they said. She didn't dress neatly and appropriately. Her desk was always a mess. Sales knew all this. She also knew why. Three years earlier, when she was 36, she was told she had attention-deficit and hyperactivity disorder. (That's the full name of the condition, and while its initials are technically a.d.h.d., not all who have it exhibit the hyperactivity symptoms, so it is often referred to conversationally as simply A.D.D.) The news was a relief because it seemed to explain everything -- why she rarely seemed to fit into a workplace, why she left nine different jobs in 1999 alone, why, despite two master's degrees and years of dogged hard work, she never seemed to get anywhere.", "headline": {"main": "Office Messes"}, "abstract": "Lisa Belkin article explores adult attention deficit hyperactivity disorder and why number of people reporting symptoms is surging; World Health Organization estimates that disorder affects 4.4 percent of adult population, making it most common psychological problem in adults after depression; adult ADHD was recognized as diagnosis in 1987 and doctors are seeing surge in adults looking for label for their lifelong restlessness; symptoms, physiology and manifestation discussed; profiles of several adults who suffer from disorder; photos (L)", "print_page": "24", "word_count": 7611, "_id": "4fd27e848eb7c8105d84791a", "snippet": "When Vivienne Sales finally broke her silence, she did so loudly, losing her temper in the hushed library where she worked. It was August 2003, and she had been hanging on to her job as a reference librarian by the most fragile of threads. For more...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/07/18/magazine/office-messes.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "WORLD HEALTH ORGANIZATION"}, {"name": "subject", "value": "ATTENTION DEFICIT HYPERACTIVITY DISORDER"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Lisa", "lastname": "Belkin"}], "original": "By Lisa Belkin"}, "document_type": "article", "pub_date": "2004-07-18T00:00:00Z", "section_name": "Magazine"}, {"type_of_material": "News", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "David Benjamin said that he expected the probing, no-nonsense questions from his probation officer: Where were you when I stopped by earlier? You remember your curfew, right? You're not down with that gang anymore? What the 17-year-old didn't expect were the concerned questions that would follow, not from his tough-minded probation officer but by the avuncular physician who accompanied the officer on the visit to David's home: How' s your blood pressure? Are you feeling dizzy? How are those headaches?", "headline": {"main": "Probation, With House Calls; Paterson Adds Health Care to Juvenile System"}, "abstract": "Hundreds of juvenile offenders in Paterson, NJ, receive visits from doctors and nurses along with their probation officers; Dr James N Pruden and nurses from Joseph' s Regional Medical Center volunteer their time to give checkups to youngsters and, sometimes, their families; recividism rate has been reduced from 37 percent to just over 5 percent since start of program in 1999; Chief John V Krieger of Passaic County Probation Division, who conceived program, believes it shows youths a more caring side of system; program costs $150,000 and is paid for by grant from state attorney general's office; photo (M)", "print_page": "1", "word_count": 1211, "_id": "4fd256ae8eb7c8105d80082b", "snippet": "David Benjamin said that he expected the probing, no-nonsense questions from his probation officer: Where were you when I stopped by earlier? You remember your curfew, right? You're not down with that gang anymore?    What the 17-year-old didn't...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/07/16/nyregion/probation-with-house-calls-paterson-adds-health-care-to-juvenile-system.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "KRIEGER, JOHN V"}, {"name": "persons", "value": "PRUDEN, JAMES N"}, {"name": "glocations", "value": "PATERSON (NJ)"}, {"name": "subject", "value": "ST JOSEPH'S REGIONAL MEDICAL CENTER (PATERSON, NJ)"}, {"name": "subject", "value": "PROBATION AND PAROLE"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "VOLUNTEERS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "CRIME AND CRIMINALS"}], "byline": {"person": [{"firstname": "Richard", "middlename": "Lezin", "lastname": "JONES", "rank": 1, "role": "reported", "organization": ""}], "original": "By RICHARD LEZIN JONES"}, "document_type": "article", "pub_date": "2004-07-16T00:00:00Z", "section_name": "Health; New York and Region"}], "meta": {"hits": 7, "offset": 0, "time": 50}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}